Cyclin-dependent kinases

Genome Biology

Volumn 15, Issue 6, 2014, Pages

  Malumbres, Marcos ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 10; CYCLIN DEPENDENT KINASE 11; CYCLIN DEPENDENT KINASE 12; CYCLIN DEPENDENT KINASE 13; CYCLIN DEPENDENT KINASE 14; CYCLIN DEPENDENT KINASE 15; CYCLIN DEPENDENT KINASE 16; CYCLIN DEPENDENT KINASE 17; CYCLIN DEPENDENT KINASE 18; CYCLIN DEPENDENT KINASE 19; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 20; CYCLIN DEPENDENT KINASE 3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE 8; CYCLIN DEPENDENT KINASE 9; RNA POLYMERASE II; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL DIVISION; CELL STRESS; CELL VIABILITY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; GENE CONTROL; HUMAN; MITOSIS; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; METABOLISM; MOLECULAR EVOLUTION; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN PROCESSING; PROTEIN TRANSPORT;

ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; HUMANS; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RNA POLYMERASE II;

EID: 84908473540     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb4184     Document Type: Article

References (67)

1. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S: The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
2. Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, Manning G, Morgan DO, Tsai LH, Wolgemuth DJ: Cyclin-dependent kinases: a family portrait. Nat Cell Biol 2009, 11:1275-1276.
3. Malumbres M, Barbacid M: Mammalian cyclin-dependent kinases. Trends Biochem Sci 2005, 30:630-641.
4. Morgan DO: Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997, 13:261-291.
5. Lim S, Kaldis P: Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development 2013, 140:3079-3093.
6. Malumbres M, Barbacid M: Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009, 9:153-166.
7. Cao L, Chen F, Yang X, Xu W, Xie J, Yu L: Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages. BMC Evol Biol 2014, 14:10.
8. Liu J, Kipreos ET: Evolution of cyclin-dependent kinases (CDKs) and CDK-activating kinases (CAKs): differential conservation of CAKs in yeast and metazoa. Mol Biol Evol 2000, 17:1061-1074.
9. Santamaria D, Barriere C, Cerqueira A, Hunt S, Tardy C, Newton K, Caceres JF, Dubus P, Malumbres M, Barbacid M: Cdk1 is sufficient to drive the mammalian cell cycle. Nature 2007, 448:811-815.
10. Ortega S, Prieto I, Odajima J, Martin A, Dubus P, Sotillo R, Barbero JL, Malumbres M, Barbacid M: Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet 2003, 35:25-31.
11. Huang D, Friesen H, Andrews B: Pho85, a multifunctional cyclin-dependent protein kinase in budding yeast. Mol Microbiol 2007, 66:303-314.
12. Davidson G, Shen J, Huang YL, Su Y, Karaulanov E, Bartscherer K, Hassler C, Stannek P, Boutros M, Niehrs C: Cell cycle control of wnt receptor activation. Dev Cell 2009, 17:788-799.
13. Mikolcevic P, Rainer J, Geley S: Orphan kinases turn eccentric: a new class of cyclin Y-activated, membrane-targeted CDKs. Cell Cycle 2012, 11:3758-3768.
14. Harashima H, Dissmeyer N, Schnittger A: Cell cycle control across the eukaryotic kingdom. Trends Cell Biol 2013, 23:345-356.
15. Carlsten JO, Zhu X, Gustafsson CM: The multitalented Mediator complex. Trends Biochem Sci 2013, 38:531-537.
16. Kohoutek J, Blazek D: Cyclin K goes with Cdk12 and Cdk13. Cell Div 2012, 7:12.
17. Guo Z, Stiller JW: Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs. BMC Genomics 2004, 5:69.
18. Echalier A, Endicott JA, Noble ME: Recent developments in cyclin-dependent kinase biochemical and structural studies. Biochim Biophys Acta 1804, 2010:511-519.
19. Pavletich NP: Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 1999, 287:821-828.
20. Day PJ, Cleasby A, Tickle IJ, O'Reilly M, Coyle JE, Holding FP, McMenamin RL, Yon J, Chopra R, Lengauer C, Jhoti H: Crystal structure of human CDK4 in complex with a D-type cyclin. Proc Natl Acad Sci U S A 2009, 106:4166-4170.
21. Takaki T, Echalier A, Brown NR, Hunt T, Endicott JA, Noble ME: The structure of CDK4/cyclin D3 has implications for models of CDK activation. Proc Natl Acad Sci U S A 2009, 106:4171-4176.
22. Mikolcevic P, Sigl R, Rauch V, Hess MW, Pfaller K, Barisic M, Pelliniemi LJ, Boesl M, Geley S: Cyclin-dependent kinase 16/PCTAIRE kinase 1 is activated by cyclin Y and is essential for spermatogenesis. Mol Cell Biol 2012, 32:868-879.
23. Boutros R, Lobjois V, Ducommun B: CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 2007, 7:495-507.
24. Jeffrey PD, Tong L, Pavletich NP: Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev 2000, 14:3115-3125.
25. Malumbres M, Barbacid M: To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 2001, 1:222-231.
26. Rubin SM: Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem Sci 2013, 38:12-19.
27. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S, Dubus P, Barbacid M: Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 2004, 118:493-504.
28. Cheung ZH, Ip NY: Cdk5: a multifaceted kinase in neurodegenerative diseases. Trends Cell Biol 2012, 22:169-175.
29. Arif A: Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5. Biochem Pharmacol 2012, 84:985-993.
30. Liu Y, Cheng K, Gong K, Fu AK, Ip NY: Pctaire1 phosphorylates Nethylmaleimide-sensitive fusion protein: implications in the regulation of its hexamerization and exocytosis. J Biol Chem 2006, 281:9852-9858.
31. Davidson G, Niehrs C: Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol 2010, 20:453-460.
32. EgloffS, Dienstbier M, Murphy S: Updating the RNA polymerase CTD code: adding gene-specific layers. Trends Genet 2012, 28:333-341.
33. Egly JM, Coin F: A history of TFIIH: two decades of molecular biology on a pivotal transcription/repair factor. DNA Repair (Amst) 2011, 10:714-721.
34. Larochelle S, Amat R, Glover-Cutter K, Sanso M, Zhang C, Allen JJ, Shokat KM, Bentley DL, Fisher RP: Cyclin-dependent kinase control of the initiationto-elongation switch of RNA polymerase II. Nat Struct Mol Biol 2012, 19:1108-1115.
35. Bres V, Yoh SM, Jones KA: The multi-tasking P-TEFb complex. Curr Opin Cell Biol 2008, 20:334-340.
36. Bartkowiak B, Liu P, Phatnani HP, Fuda NJ, Cooper JJ, Price DH, Adelman K, Lis JT, Greenleaf AL: CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev 2010, 24:2303-2316.
37. Blazek D, Kohoutek J, Bartholomeeusen K, Johansen E, Hulinkova P, Luo Z, Cimermancic P, Ule J, Peterlin BM: The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev 2011, 25:2158-2172.
38. Clemente-Blanco A, Sen N, Mayan-Santos M, Sacristan MP, Graham B, Jarmuz A, Giess A, Webb E, Game L, Eick D, Bueno A, Merkenschlager M, Aragon L: Cdc14 phosphatase promotes segregation of telomeres through repression of RNA polymerase II transcription. Nat Cell Biol 2011, 13:1450-1456.
39. Guillamot M, Manchado E, ChiesaM, Gomez-Lopez G, Pisano DG, SacristanMP, Malumbres M: Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription. Sci Rep 2011, 1:189.
40. Galbraith MD, Donner AJ, Espinosa JM: CDK8: a positive regulator of transcription. Transcription 2010, 1:4-12.
41. Sato S, Tomomori-Sato C, Parmely TJ, Florens L, Zybailov B, Swanson SK, Banks CA, Jin J, Cai Y, Washburn MP, Conaway JW, Conaway RC: A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Mol Cell 2004, 14:685-691.
42. Hu D, Mayeda A, Trembley JH, Lahti JM, Kidd VJ: CDK11 complexes promote pre-mRNA splicing. J Biol Chem 2003, 278:8623-8629.
43. Drogat J, Migeot V, Mommaerts E, Mullier C, Dieu M, van Bakel H, Hermand D: Cdk11-cyclinL controls the assembly of the RNA polymerase II mediator complex. Cell Rep 2012, 2:1068-1076.
44. Wilkinson S, Croft DR, O'Prey J, Meedendorp A, O'Prey M, Dufes C, Ryan KM: The cyclin-dependent kinase PITSLRE/CDK11 is required for successful autophagy. Autophagy 2011, 7:1295-1301.
45. Wang Y, Zong H, Chi Y, Hong Y, Yang Y, Zou W, Yun X, Gu J: Repression of estrogen receptor alpha by CDK11p58 through promoting its ubiquitinproteasome degradation. J Biochem 2009, 145:331-343.
46. Chi Y, Hong Y, Zong H, Wang Y, Zou W, Yang J, Kong X, Yun X, Gu J: CDK11p58 represses vitamin D receptor-mediated transcriptional activation through promoting its ubiquitin-proteasome degradation. Biochem Biophys Res Commun 2009, 386:493-498.
47. Petretti C, Savoian M, Montembault E, Glover DM, Prigent C, Giet R: The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. EMBO Rep 2006, 7:418-424.
48. Hu D, Valentine M, Kidd VJ, Lahti JM: CDK11(p58) is required for the maintenance of sister chromatid cohesion. J Cell Sci 2007, 120:2424-2434.
49. Yokoyama H, Gruss OJ, Rybina S, Caudron M, Schelder M, Wilm M, Mattaj IW, Karsenti E: Cdk11 is a RanGTP-dependent microtubule stabilization factor that regulates spindle assembly rate. J Cell Biol 2008, 180:867-875.
50. Guen VJ, Gamble C, Flajolet M, Unger S, Thollet A, Ferandin Y, Superti-Furga A, Cohen PA, Meijer L, Colas P: CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome. Proc Natl Acad Sci U S A 2013, 110:19525-19530.
51. Liu W, Cai MJ, Wang JX, Zhao XF: In a non-genomic action, steroid hormone 20-hydroxyecdysone induces phosphorylation of cyclin-dependent kinase 10 to promote gene transcription. Endocrinology 2014, 155:1738-1750.
52. Wohlbold L, Larochelle S, Liao JC, Livshits G, Singer J, Shokat KM, Fisher RP: The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity. Cell Cycle 2006, 5:546-554.
53. Fu Z, Larson KA, Chitta RK, Parker SA, Turk BE, Lawrence MW, Kaldis P, Galaktionov K, Cohn SM, Shabanowitz J, Hunt DF, Sturgill TW: Identification of yin-yang regulators and a phosphorylation consensus for male germ cell-associated kinase (MAK)-related kinase. Mol Cell Biol 2006, 26:8639-8654.
54. Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, Zhao GJ, Ng SS, Lin MC, Yu J, Lai PB, To KF, Sung JJ: Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Invest 2011, 121:3159-3175.
55. Yang Y, Roine N, Makela TP: CCRK depletion inhibits glioblastoma cell proliferation in a cilium-dependent manner. EMBO Rep 2013, 14:741-747.
56. Aleem E, Kiyokawa H, Kaldis P: Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol 2005, 7:831-836.
57. Kollmann K, Heller G, Schneckenleithner C, Warsch W, Scheicher R, Ott RG, Schafer M, Fajmann S, Schlederer M, Schiefer AI, Reichart U, Mayerhofer M, Hoeller C, Zochbauer-Muller S, Kerjaschki D, Bock C, Kenner L, Hoefler G, Freissmuth M, Green AR, Moriggl R, Busslinger M, Malumbres M, Sexl V: A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell 2013, 24:167-181.
58. Handschick K, Beuerlein K, Jurida L, Bartkuhn M, Muller H, Soelch J, Weber A, Dittrich-Breiholz O, Schneider H, Scharfe M, Jarek M, Stellzig J, Schmitz ML, Kracht M: Cyclin-dependent kinase 6 is a chromatin-bound cofactor for NF-kappaB-dependent gene expression. Mol Cell 2014, 53:193-208.
59. http://www.focr.org/breakthrough-therapies.
60. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M, Hahn WC: CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008, 455:547-551.
61. Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS, Kwon EJ, Haigis KM, Naar AM, Dyson NJ: E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 2008, 455:552-556.
62. Iorns E, Turner NC, Elliott R, Syed N, Garrone O, Gasco M, Tutt AN, Crook T, Lord CJ, Ashworth A: Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell 2008, 13:91-104.
63. Bajrami I, Frankum JR, Konde A, Miller RE, Rehman FL, Brough R, Campbell J, Sims D, Rafiq R, Hooper S, Chen L, Kozarewa I, Assiotis I, Fenwick K, Natrajan R, Lord CJ, Ashworth A: Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity. Cancer Res 2014, 74:287-297.
64. Leung WK, Ching AK, Chan AW, Poon TC, Mian H, Wong AS, To KF, Wong N: A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility. Oncogene 2011, 30:4464-4475.
65. Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, Zhu ZD, Zhou B, Liu XY, Liu RF, Fei QL, Chen H, Cai B, Xiao HS, Qin LX, Han ZG: Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet 2012, 44:1117-1121.
66. Ma Z, Wu Y, Jin J, Yan J, Kuang S, Zhou M, Zhang Y, Guo AY: Phylogenetic analysis reveals the evolution and diversification of cyclins in eukaryotes. Mol Phylogenet Evol 2013, 66:1002-1010.
67. Chen J, Larochelle S, Li X, Suter B: Xpd/Ercc2 regulates CAK activity and mitotic progression. Nature 2003, 424:228-232.